Literature DB >> 33646429

Central Hepatectomy Versus Major Hepatectomy for Centrally Located Hepatocellular Carcinoma: A Propensity Score Matching Study.

Tatsuya Orimo1, Toshiya Kamiyama2, Tatsuhiko Kakisaka2, Shingo Shimada2, Akihisa Nagatsu2, Yoh Asahi2, Yuzuru Sakamoto2, Hirofumi Kamachi2, Akinobu Taketomi2.   

Abstract

BACKGROUND: In terms of anatomical liver sectionectomy approaches, both a central hepatectomy (CH) and major hepatectomy (MH) are feasible options for a centrally located hepatocellular carcinoma (HCC).
METHODS: We retrospectively reviewed the surgical outcomes of central HCC patients who underwent CH or MH. MH includes hemihepatectomy or trisectionectomy, whereas CH involves a left medial sectionectomy, right anterior sectionectomy, or central bisectionectomy. The surgical outcomes were compared before and after propensity score matching (PSM).
RESULTS: A total of 233 patients were enrolled, including 132 in the CH group and 101 in the MH group. The MH group cases were pathologically more advanced and had poorer overall survival rates than the CH group. After PSM, 68 patients were selected into each group, both of which showed similar overall and recurrence-free survival outcomes. The CH group showed a tendency for a longer operation time; however, other perioperative outcomes were similar between the two groups. Multivariate analyses of our matched HCC patients revealed that the type of surgery (CH or MH) was not an independent prognostic factor. More patients in the matched CH group experienced a repeat hepatectomy for recurrence and no patients in this group underwent a preoperative portal vein embolization.
CONCLUSIONS: The short- and long-term surgical outcomes of CH and MH for a centrally located HCC are similar under a matched clinicopathological background. CH has the advantage of not requiring a preoperative portal vein embolization and increased chances of conducting a repeat hepatectomy for recurrence.

Entities:  

Year:  2021        PMID: 33646429     DOI: 10.1245/s10434-021-09751-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  1 in total

1.  Surgery for Recurrent Hepatocellular Carcinoma: Achieving Long-term Survival.

Authors:  Tomoaki Yoh; Satoru Seo; Kojiro Taura; Kohta Iguchi; Satoshi Ogiso; Ken Fukumitsu; Takamichi Ishii; Toshimi Kaido; Shinji Uemoto
Journal:  Ann Surg       Date:  2021-04-01       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.